Rosewood was a show built on a simple idea: a private pathologist with access to the latest tech helps cops solve crimes nobody else can crack. That idea should work. In practice, it barely holds together.
The series ran for two seasons, 44 episodes, from 2015 to 2017, on FOX. It starred Morris Chestnut as Dr. Beaumont Rosewood Jr., a man described as brilliant and driven to live life to the fullest. The premise promised a blend of crime-solving and cutting-edge science. What it delivered was mostly filler.
Trailer, via TV Promos.
Beaumont Rosewood Jr.
Dr. Beaumont Rosewood Jr. runs a private pathology practice in Miami. He has a drive to live life to the fullest, and he uses that energy to help a tough-as-nails detective and the Miami PD find clues no one else can see. That’s the pitch. The execution rarely matches it.
The show’s central weakness is its pacing. Episodes often stretch the same setup across multiple episodes, repeating the same scenes and setups week after week. The plot doesn’t move forward so much as circle around itself.
“Fox picked up Rosewood for a full season of 22 episodes.”
That decision came on October 16, 2015, about a month after the series premiered. The renewal for a second season arrived on April 7, 2016. The cancellation followed on May 9, 2017.
The Cast
Morris Chestnut carries the show. He plays Dr. Beaumont Rosewood Jr. with a confident, energetic presence that sells the character’s brilliance even when the writing around him falters. His scenes are the best reason to keep watching.
Anna Konkle appears as Tara Milly Izikoff, and Lorraine Toussaint plays Donna Rosewood, the doctor’s mother. Domenick Lombardozzi shows up as Ira Hornstock, and Jaina Lee Ortiz takes on Annalise Villa. Gabrielle Dennis plays Pippy Rosewood, and Eddie Cibrian rounds out the main group as Ryan Slade.
The cast is capable. The material isn’t always kind to them.
The Crime Procedure
The show is a police procedural, meaning it follows investigations from start to finish. Rosewood’s role is to provide the forensic insight that moves cases forward. The problem is that the show rarely builds cases around the pathologist’s skills in interesting ways.
Instead, it leans on stock crime-procedural tropes:
- The autopsy that reveals a hidden wound
- The DNA test that clears a suspect
- The witness who remembers something after hypnosis
These tools are familiar, and the show doesn’t dress them up enough to feel fresh.
The Science
The premise promises wildly sophisticated technology. The show delivers some gadgets and computer screens, but it never explains how they work or why they matter. A brilliant private pathologist should be doing something that feels genuinely new. Rosewood rarely does.
The result is a show that looks like a procedural without offering the payoff of a procedural. Viewers get the setup but not the follow-through.
The Writing
The dialogue is flat. Characters talk in service of the plot rather than as people with their own voices. Lines are delivered without much tension, and scenes often feel like they’re being explained rather than shown.
The show also struggles with tone. It wants to be serious, but it keeps leaning toward camp. The contrast between a brilliant pathologist and a tough-as-nails detective is meant to be funny. More often, it just feels off.
The Second Season
The second season premiered on September 22, 2016. It brought back the same formula with a few new cases. Nothing changed underneath. The show remained repetitive, with the same pacing issues from the first season.
The renewal suggests Fox believed in the concept. The cancellation suggests the network saw the flaws. Both are true.
The Cancellation
Fox cancelled Rosewood on May 9, 2017, after two seasons and 44 episodes. The show had run its course. It had exhausted its premise without ever reaching a satisfying conclusion.
The show ended without resolving its central question: what makes Dr. Beaumont Rosewood Jr. special. The answer was never fully explained. The ending felt rushed, as though the network simply decided the show had run long enough.
Where It Lands
Rosewood had a strong premise. It had a capable lead actor. It had a network willing to give it time. None of that mattered when the show couldn’t deliver a compelling story week after week.
The show is most effective when it focuses on Chestnut’s performance. The rest of the cast is wasted on a script that doesn’t know what to do with them. The technology is a promise that never pays off. The crime stories are routine.
Rosewood is a show that never finds its footing. It tries to be a crime drama, a character study, and a showcase for tech. It succeeds at none of them.
The final verdict: 3.7 of 10.
Get the Notebook.
The day's best stories and every fresh verdict, in plain English, in your inbox by seven. One email a day, no more.
